Richard T. LeBuhn, Director at Asterias Biotherapeutics, Inc. (AST), bought 5,000 shares at $4.41 ($22K) on 2015-06-25, disclosed to the SEC on 2015-06-26.
Open-market purchase of $22k AST by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CMRO | BUY | 2013-02-22 | $10K | — | Filing → |